Evidence map›Paper›PMID 41164231›Full record

ArticleFrontiers in veterinary science2025

One year duration of immunity of a combination

Sarah A Wiechert-Brown, Haley M Classe, Jennifer C Dant, Rhonda L LaFleur, Zach Xu, Ian Tarpey

Abstract read
In one paragraph

Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sarah A Wiechert-Brown *Research and Development Department, Merck Animal Health, Elkhorn, NE, United States.
Haley M Classe *Research and Development Department, Merck Animal Health, Elkhorn, NE, United States.
Jennifer C DantResearch and Development Department, Merck Animal Health, Elkhorn, NE, United States.
Rhonda L LaFleurResearch and Development Department, Merck Animal Health, Elkhorn, NE, United States.
Zach XuResearch and Development Department, Merck Animal Health, Elkhorn, NE, United States.
Ian TarpeyResearch and Development Department, MSD Animal Health, Boxmeer, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Canine infectious respiratory disease complex (CIRDC), widely known as kennel cough or infectious tracheobronchitis, is a highly contagious disease in dogs caused by multiple bacterial and viral pathogens. Two significant pathogens that contribute to CIRDC are Methods: To evaluate the efficacy of both fractions of this vaccine, duration of immunity studies were conducted in six- to eight-week-old beagles. In both studies, dogs were randomized into two treatment groups and vaccinated once by the oral route with either test vaccine or placebo vaccine. In the CPI study, dogs were challenged with virulent CPI one year after vaccination and observed daily for 14 days post-challenge. Nasal swabs were also collected daily for 10 days post-challenge to evaluate the shedding of the challenge virus. In the Results: The results from these studies demonstrated a significant reduction in nasal shedding of CPI (0.2 log Conclusion: Taken together, these studies demonstrated that oral vaccination with a combination vaccine containing

Indexed as

Bordetella bronchisepticacanineoralparainfluenzavaccination

Identifiers

PMID41164231
PMCPMC12558751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.